Screener
Eton Pharmaceuticals, Inc. ETON Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | For the three months ended / March 31, 2026 | For the three months ended / March 31, 2025 |
|---|---|---|
| Revenues: | ||
| Licensing revenue | — | $3,286 |
| Product sales and royalties, net | 24,266 | 13,996 |
| Total net revenues | 24,266 | 17,282 |
| Cost of sales: | ||
| Licensing revenue | — | 825 |
| Product sales and royalties | 9,531 | 6,596 |
| Total cost of sales | 9,531 | 7,421 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s total revenue?
- Eton Pharmaceuticals, Inc. (ETON) reported total revenue of $24.27M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total revenue changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total revenue increased by 40.4% year-over-year, from $17.28M to $24.27M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s total revenue has grown at a 38.3% compound annual growth rate (CAGR), from $21.83M to $79.95M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Eton Pharmaceuticals, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude